Policy
Bora supports the principles of ecosystem conservation and is committed to avoiding damage to natural habitats during operations. We assess
whether our operating sites are located in ecologically sensitive areas and implement corresponding protection or monitoring measures based on the level of risk.
We actively manage water resources, waste, and air pollution to reduce potential impacts on local ecosystems, with particular attention to protecting natural resources near our facilities, such as rivers and green spaces.
Biodiversity considerations are incorporated into our environmental management systems. We strengthen the assessment and monitoring of ecological impacts across our supply chain and internal operations and encourage partners to jointly promote responsible resource use and conservation efforts.
Our Goals
- Conduct regular assessments of ecological sensitivity across operating sites and establish a preliminary database of potential risk areas.
- Enhance monitoring mechanisms for wastewater, air emissions, and waste discharge during operations to ensure regulatory compliance and minimize disturbance to natural habitats.
- Promote employee environmental education and training programs that include biodiversity and habitat conservation concepts to raise overall environmental awareness.
- For any major construction or site expansion in the future, ecological impact assessments will be incorporated into planning processes to ensure early warning and response measures are in place before development begins.
As biodiversity is increasingly recognized for its vital role in pharmaceutical research and development, Bora Pharmaceuticals acknowledges its close connection to innovation and sustainable development. We plan to integrate biodiversity into our ESG strategy, support the Convention on Biological Diversity, and actively implement conservation actions throughout our operations and supply chain to ensure harmonious coexistence between business development and the natural environment.